Project Grant HT94252510838
Award Date 8/15/25
Completion Date 8/14/28
Dollars Obligated $822K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
- This federal Project Grant award, valued at $1,316,000.00 and awarded by the Defense Health Agency, is funding research to advance understanding of the WRN gene as a therapeutic target for microsatellite instability-high (MSI-H) cancers. The research is being conducted by The Trustees of Columbia University in the City of New York, through its Health Sciences Division, under the Military Medical Research and Development program (CFDA 12.420). The research aims to transform healthcare for...
- This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research conducted by The Trustees of Columbia University in the City of New York, specifically the Health Sciences Division. The $1,644,999 award, effective July 1, 2025, funds a 3-year research project to investigate the role of Streptococcus in esophageal neoplasia. This research aims to advance scientific understanding and develop potential...
- The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, was awarded a $656,272 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research aimed at optimizing PD-1 immunotherapy through increased T cell regeneration and reduced antigen load. This 2-year project will be conducted in New York, NY from September 1, 2023 to August 31, 2025. The Military Medical...
- The Defense Health Agency awarded a $159,892 Project Grant to the University of Illinois under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports research into "Metabolic Vulnerabilities Associated to G12C Inhibitor Resistance" from January 1, 2022 through December 31, 2023. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will...
- This $879,721 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research to evaluate small molecule ferroptosis inhibitors in a Gtp4-associated amyotrophic lateral sclerosis (ALS) model at Columbia University. The research aims to transform healthcare for military service members and the broader public by developing innovative medical solutions to address critical health challenges. The award is effective from...
- The Defense Health Agency awarded a $658,000 Project Grant to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "OVERCOMING IMMUNOTHERAPY RESISTANCE IN CCNE1-AMPLIFIED STOMACH CANCER", is intended to support research to improve treatment options for stomach cancer patients. The 3-year project will run from May 1, 2024 to April 30, 2027....
- The Defense Health Agency awarded a $197,400 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, with a performance period from February 15, 2025 to February 14, 2026. The grant supports the "Development of Patient-Derived CNS Metastasis Models with STK11 Inactivation for Drug Discovery." As a leading academic research institution, Columbia...
- The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
- This federal Project Grant award of $1,645,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is for a research project titled "TREATING HER2 THERAPY-RESISTANT BRAIN METASTASIS USING ANTIDEPRESSANTS." The award was granted to The Trustees of Columbia University in the City of New York, Health Sciences Division, and runs from Jul 1, 2025 to Jun 30, 2028. The project aims to conduct advanced biomedical research to investigate the use...
- The federal Project Grant award of $1,214,375.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), is funding a research project led by Yale University. The project is investigating the use of decoy-resistant IL-18 and immune checkpoint inhibitors in preclinical murine and ex vivo patient-derived models of renal cell carcinoma. The award began on September 15, 2024 and is set to conclude on September 14, 2028. The Military Medical Research...